27 results
8-K
EX-99.1
bsummawvfb8fb4
26 May 22
Axcella Announces Completion of Enrollment of Clinical Trial for Long COVID and Has Prioritized its Clinical Portfolio
8:12am
424B5
iy50uiz1m6 9q
16 Mar 22
Prospectus supplement for primary offering
8:00am
424B5
3mukwj 0t
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
EX-99.1
6nqgf5afr6nbkg8dvf
11 May 20
Axcella Reports First Quarter Financial Results and Provides Business Update
8:13am
8-K
EX-99.1
w8gb1 bcaqqtx
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.1
uka u9yang8r8thc4e
1 Nov 22
Axcella Reports Third Quarter Financial Results and Provides Business Update
8:02am
8-K
EX-99.1
9uoevy
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am